Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression
Author:
Minxuan Xu,Junjie Zhao,Liancai Zhu,Chenxu Ge,Yan Sun,Ranran Wang,Yuanyuan Li,Xianling Dai,Qin Kuang,Linfeng Hu,Jing Luo,Gang Kuang,Yanrong Ren,Bochu Wang,Jun Tan,Shengbin Shi
Publication:
Journal of Hepatology
© 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.